Literature DB >> 1701944

Two noncontiguous regions of Sendai virus P protein combine to form a single nucleocapsid binding domain.

K W Ryan1, E M Morgan, A Portner.   

Abstract

Binding of Sendai virus P protein to viral nucleocapsids requires amino acids in two separate regions of P protein. Both required regions are near the carboxyl terminus, and they are separated by a region which is expendable for binding (K. W. Ryan and A. Portner, 1990, Virology 174, 515-521). To examine the topography of these regions in the folded P protein molecule we mapped the epitopes present in several undenatured P proteins with overlaping deletions near their carboxyl termini. The epitopes recognized by two monoclonal antibodies were each composed of both protein regions necessary for binding, indicating that these two regions are each required at some point during the folding of P protein. To determine if these protein regions interact directly in forming the nucleocapsid binding domain, we constructed a deleted P gene which encodes a protein comprising only these two regions with all other P protein sequences deleted. This protein was able to bind to nucleocapsids, demonstrating that these two regions alone are sufficient to form the nucleocapsid-binding domain. In addition, this protein formed the folded epitopes comprising the two nucleocapsid-binding regions, indicating that the two regions interact directly with each other to form a single folded structure. The involvement of this binding domain in viral mRNA synthesis was examined by testing the ability of each monoclonal antibody to inhibit the in vitro transcription activity of full-size P protein. Several antibodies to epitopes near the binding domain were found to be potent inhibitors of viral transcription, showing that these regions contribute to P protein's role in mRNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1701944     DOI: 10.1016/0042-6822(91)90016-5

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  15 in total

1.  The C-terminal 88 amino acids of the Sendai virus P protein have multiple functions separable by mutation.

Authors:  Jeffery Tuckis; Sherin Smallwood; Joyce A Feller; Sue A Moyer
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  A novel P/V/C gene in a new member of the Paramyxoviridae family, which causes lethal infection in humans, horses, and other animals.

Authors:  L F Wang; W P Michalski; M Yu; L I Pritchard; G Crameri; B Shiell; B T Eaton
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  A role for the Sendai virus P protein trimer in RNA synthesis.

Authors:  J Curran
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

4.  Importance of the cysteine-rich carboxyl-terminal half of V protein for Sendai virus pathogenesis.

Authors:  A Kato; K Kiyotani; Y Sakai; T Yoshida; T Shioda; Y Nagai
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Sequence determination and molecular analysis of two strains of bovine parainfluenza virus type 3 that are attenuated for primates.

Authors:  J E Bailly; J M McAuliffe; M H Skiadopoulos; P L Collins; B R Murphy
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

6.  Identification of protein regions involved in the interaction of human respiratory syncytial virus phosphoprotein and nucleoprotein: significance for nucleocapsid assembly and formation of cytoplasmic inclusions.

Authors:  B García-Barreno; T Delgado; J A Melero
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication.

Authors:  J Curran; J B Marq; D Kolakofsky
Journal:  J Virol       Date:  1995-02       Impact factor: 5.103

8.  Role of NH(2)- and COOH-terminal domains of the P protein of human parainfluenza virus type 3 in transcription and replication.

Authors:  B P De; M A Hoffman; S Choudhary; C C Huntley; A K Banerjee
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

9.  Measles virus phosphoprotein gene products: conformational flexibility of the P/V protein amino-terminal domain and C protein infectivity factor function.

Authors:  Patricia Devaux; Roberto Cattaneo
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

10.  Characterization of nucleocapsid binding by the measles virus and mumps virus phosphoproteins.

Authors:  Richard L Kingston; Walter A Baase; Leslie S Gay
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.